Federal Register - September 3, 2021

Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.

Fuente: Federal Register

Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices DEPARTMENT OF HEALTH AND
HUMAN SERVICES

FOR FURTHER INFORMATION CONTACT:

Centers for Medicare & Medicaid Services
SUPPLEMENTARY INFORMATION:

William Parham at 410 7864669.

Document Identifier: CMS10637

Agency Information Collection Activities: Submission for OMB
Review; Comment Request Centers for Medicare &
Medicaid Services, Health and Human Services HHS.
ACTION: Notice.
AGENCY:

The Centers for Medicare &
Medicaid Services CMS is announcing an opportunity for the public to comment on CMS intention to collect information from the public. Under the Paperwork Reduction Act of 1995
PRA, federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agencys functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

SUMMARY:

Comments on the collections of information must be received by the OMB desk officer by October 4, 2021.
ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/
PRAMain . Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function.
To obtain copies of a supporting statement and any related forms for the proposed collections summarized in this notice, you may make your request using one of following:
1. Access CMS website address at website address at: https
www.cms.gov/Regulations-andGuidance/Legislation/Paperwork ReductionActof1995/PRA-Listing.html.

lotter on DSK11XQN23PROD with NOTICES1

DATES:

VerDate Sep<11>2014

16:55 Sep 02, 2021

Jkt 253001

Under the Paperwork Reduction Act of 1995 PRA
44 U.S.C. 35013520, federal agencies must obtain approval from the Office of Management and Budget OMB for each collection of information they conduct or sponsor. The term collection of information is defined in 44 U.S.C.
35023 and 5 CFR 1320.3c and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506c2A of the PRA 44 U.S.C.
3506c2A requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collections of information for public comment:
1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Marketplace Operations; Use: The data collections and third-party disclosure requirements will assist HHS in determining Exchange compliance with Federal standards and monitoring QHP issuers in FFEs for compliance with Federal QHP issuer standards. The data collection will also assist HHS in monitoring Web-brokers for compliance with Federal Web-broker standards. The data collected by health insurance issuers and Exchanges will help to inform HHS, Exchanges, and health insurance issuers as to the participation of individuals, employers, and employees in the individual Exchange, the SHOP, and the premium stabilization programs. Form Number:
CMS10637 OMB control number 09381353; Frequency: Annually;
Affected Public: Private sector Business or other for-profits; Number of Respondents: 3,902; Total Annual Responses: 3,902; Total Annual Hours:
2,336,190. For policy questions regarding this collection contact:
Nikolas Berkobien at 3014924400.

Dated: August 31, 2021.
William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs.
FR Doc. 202119142 Filed 9221; 8:45 am BILLING CODE 412001P

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

49537

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration Docket No. FDA2019N3402

Advisory Committee; National Mammography Quality Assurance Advisory Committee; Renewal Food and Drug Administration, Health and Human Services HHS.
ACTION: Notice; renewal of advisory committee.
AGENCY:

The Food and Drug Administration FDA is announcing the renewal of the National Mammography Quality Assurance Advisory Committee by the Commissioner of Food and Drugs the Commissioner. The Commissioner has determined that it is in the public interest to renew the National Mammography Quality Assurance Advisory Committee for an additional 2
years beyond the charter expiration date. The new charter will be in effect until July 7, 2023, expiration date.
DATES: Authority for the National Mammography Quality Assurance Advisory Committee will expire on July 7, 2023, unless the Commissioner formally determines that renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT:
Aden Asefa, Office of Management, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5214, Silver Spring, MD 20993
0002, 3017960400, email:
aden.asefa@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 1023.65 and approval by the Department of Health and Human Services pursuant to 45 CFR part 11 and by the General Services Administration, FDA is announcing the renewal of the National Mammography Quality Assurance Advisory Committee the Committee. The committee is a nondiscretionary Federal advisory committee established to provide advice to the Commissioner.
The Commissioner is charged with the administration of the Federal Food, Drug and Cosmetic Act and various provisions of the Public Health Service Act. The Mammography Quality Standards Act of 1992 amends the Public Health Service Act to establish national uniform quality and safety standards for mammography facilities.
The National Mammography Quality Assurance Advisory Committee advises the Secretary and, by delegation, the Commissioner or designee in discharging their responsibilities with SUMMARY:

E:FRFM03SEN1.SGM

03SEN1

Acerca de esta edición

Federal Register - September 3, 2021

TítuloFederal Register

PaísEstados Unidos de América

Fecha03/09/2021

Nro. de páginas449

Nro. de ediciones7801

Primera edición14/03/1936

Ultima edición24/06/2026

Descargar esta edición

Otras ediciones

<<<Septiembre 2021>>>
DLMMJVS
1234
567891011
12131415161718
19202122232425
2627282930